Attached files
| file | filename |
|---|---|
| EXCEL - IDEA: XBRL DOCUMENT - PROLUNG INC | Financial_Report.xls |
| EX-31.2 - EXHIBIT 31.2 SECTION 302 CERTIFICATIONS - PROLUNG INC | f10qa063012_ex31z2.htm |
| EX-32.2 - EXHIBIT 32.2 SECTION 906 CERTIFICATIONS - PROLUNG INC | f10qa063012_ex32z2.htm |
| EX-31.1 - EXHIBIT 31.1 SECTION 302 CERTIFICATIONS - PROLUNG INC | f10qa063012_ex31z1.htm |
| 10-Q/A - JUNE 30, 2012 10-Q/A - PROLUNG INC | f10qa063012_10qz.htm |
EXHIBIT 32.1
CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350
AS ADOPTED PURSUANT TO SECTION 906
OF THE SARBANES-OXLEY ACT OF 2002
The undersigned hereby certifies, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that this Quarterly Report on Form 10-Q/A for the quarter ended June 30, 2012 fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended, and the information contained in such report fairly presents, in all material respects, the financial condition and results of operations of Fresh Medical Laboratories, Inc.
/s/ Steven C. Eror | Date: September 7, 2012 |
Steven C. Eror Chief Executive Officer and Director | |